Next Article in Journal
Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
Next Article in Special Issue
Salivary Microbiota Shifts under Sustained Consumption of Oolong Tea in Healthy Adults
Previous Article in Journal
Effects of Beetroot Juice Ingestion on Physical Performance in Highly Competitive Tennis Players
Previous Article in Special Issue
Possible Involvement of Vitamin C in Periodontal Disease-Diabetes Mellitus Association
Open AccessEditorial

Current Evidence of Natural Agents in Oral and Periodontal Health

Department of General Surgery and Surgical-Medical Specialties, Unit of Oral Surgery and Periodontology, School of Dentistry, University of Catania, Via S. Sofia 78, 95124 Catania, Italy
Nutrients 2020, 12(2), 585;
Received: 30 January 2020 / Revised: 10 February 2020 / Accepted: 12 February 2020 / Published: 24 February 2020


Oral and periodontal diseases, chewing disorders, and many destructive inflammatory diseases of the supporting tissues of the teeth are usually caused by an imbalance between host defense and environmental factors like smoking, poor nutrition, and a high percentage of periodontopathogenic bacteria. For these reasons, it is important also to focus attention on plaque control and also on improving host resistance through smoking and stress reduction, and a healthy diet. During the last decades, the importance of micronutrients has been extensively reviewed, and it was concluded that the prevention and treatment of periodontitis should include correct daily nutrition and a correct balance between antioxidants, probiotics, natural agents, vitamin D, and calcium. Recently, there has been growing interest in the literature on the impact of nutraceutical dietary aliments on oral and general health. This Special Issue provides a current and thoughtful perspective on the relationship of diet and natural agents on oral and periodontal diseases through a correct clinical approach with the last and most important evidence that may determine good oral conditions and high quality of life.
Keywords: periodontitis; natural agents; gingivitis; antioxidants; vitamins periodontitis; natural agents; gingivitis; antioxidants; vitamins
It has been widely demonstrated that herbal medicines, which include medicinal herbs, herbal preparations, and phytotherapeutic compounds (that have plant or natural materials), have real therapeutic benefits for humans [1,2,3]. Worldwide, about 80% of the population uses phytotherapeutic products such as extracts, vitamins, tea, and other similar principles for various reasons for the treatment of various pathologies, with a cost of over 50 billion dollars a year in the global market [4]. This high consumption of herbal products compared to traditional drugs, such as antibiotics, is attributable to the large margin of safety and tolerability of natural agents, which could lead to a possible reduction in the long-term on the total national economic costs compared to traditional drugs. In addition, conventional drugs have also been shown to have a higher incidence of side effects, allergies, and resistance, especially antibiotics [5,6]. Therefore, herbal medicines are increasingly being used both as food supplements and to prevent or treat common oral and systemic diseases [5].
Among the main diseases of the stomatognathic apparatus, periodontitis is a chronic inflammatory disease caused by oral bacteria that determines the destruction of the supporting structures of the teeth [7,8,9]. The etiology of periodontitis is multifactorial with the bacteria of the oral biofilm which are fundamental for the initiation and progression of the disease. The different forms of periodontal disease are very different around the world but reach a total incidence rate of over 60%. The bacterial origin of periodontitis has been widely demonstrated, starting from an imbalance in aerobic and anaerobic biofilm bacteria [10], which can lead, under specific conditions, to activation of the host response, especially of neutrophilic bacteria and related products, which determines the disruption of soft and hard oral tissues [11,12,13]. This imbalance of the host response through the immune system results in further up or down-regulation of various pro-inflammatory cytokines, which finally determines the release of rapid oxidative stress (ROS) cells and neutrophil mediators [14,15]. This prolonged inflammatory status on the hard and soft tissues of the periodontium, including the connective tissue, leads to the degradation and consequent loss of the periodontal structure of the tooth and of the alveolar bone, causing, in the final disease steps, tooth loss [16].
Several studies have shown, in damaged periodontal tissues, a direct association between increased levels of inflammatory mediators induced by reactive oxygen species (such as NO) and the worsening of periodontitis [17,18]. Therefore, herbal medicines have been demonstrated to have an important role due to their broad spectrum of action against ROS and NO mediators, together with a good safety and tolerability margin compared with traditional drugs in both children and adults [19,20,21,22,23].
A good adjuvant response in both surgical and nonsurgical periodontal treatment has been shown in recent years by natural agents. Especially in the non-surgical approach, various antimicrobials and chemotherapy agents, including chlorhexidine, triclosan, desiccant agents, vitamin and probiotic compounds, and cetylpyridinium chloride, have been studied and validated for the management of periodontitis [24,25,26,27,28,29]. However, even more studies have aimed at analyzing phytotherapeutic drugs in order to obtain antimicrobial, antiseptic, anti-inflammatory, and antioxidant effects during periodontitis.
In fact, herbal medicines have been shown to possess a wide and specific range of biological properties including antimicrobial, antioxidant and anti-inflammatory effects at the oral and systemic levels. The natural phytotherapeutic compounds, including medicinal herbs, help to suppress the inflammatory response, which determines, in the long term, the destruction of the hard and soft tissues of the oral cavity, characteristic in various oral diseases, including periodontitis [30,31,32,33,34]. Among the main anti-inflammatory actions due to phytotherapy drugs, there is, above all, an anti-inflammatory and oxidative action which leads to excellent therapeutic action in the long-term. However, on the other hand, various studies in the oral field that have analyzed the actions of traditional and phytotherapeutic drugs have given uncertain results that require large-scale populations to be validated [35,36,37,38,39].
Based on these findings, the aim of this Special Issue is to further analyze the therapeutic effects of these medicinal herbs, phytotherapy, and of the main inflammatory mediator characteristics of oral and periodontal diseases.
Given the many new aspects related to the optimal management of phytotherapy drugs in dentistry, it was my pleasure to receive publications detailing the results of different joint research groups for this highly stimulating Special Issue on this subject that is aimed at analyzing and validating new scientific approaches to improve the prevention and treatment of oral and periodontal diseases through the use of phytotherapeutic drugs.

Author Contributions

Conceptualization, writing—original draft preparation, G.I.; G.I. has read and agreed to the published version of the manuscript.


This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.


  1. Tambekar, D.H.; Dahikar, S.B.; Lahare, M.D. Antibacterial potentials of some herbal preparations available in India. Res. J. Med. Med. Sci. 2009, 4, 224–227. [Google Scholar]
  2. Mohammed, H.; Varoni, E.M.; Cochis, A.; Cordaro, M.; Gallenzi, P.; Patini, R.; Staderini, E.; Lajolo, C.; Rimondini, L.; Rocchetti, V. Oral dysbiosis in pancreatic cancer and liver cirrhosis: A review of the literature. Biomedicines 2018, 4, 115. [Google Scholar] [CrossRef] [PubMed]
  3. Patini, R.; Gallenzi, P.; Spagnuolo, G.; Cordaro, M.; Cantiani, M.; Amalfitano, A.; Arcovito, A.; Callà, C.A.M.; Mingrone, G.; Nocca, G. Correlation between metabolic syndrome, periodontitis and reactive oxygen species production. A pilot study. Open Dent. J. 2017, 11, 621–627. [Google Scholar] [CrossRef]
  4. World Health Organization. The World Medicines Situation 2011. In Traditional Medicines: Global Situation, Issues and Challenges; WHO: Geneva, Switzerland, 2011; pp. 1–14. [Google Scholar]
  5. Wu, Y.H.; Kuraji, R.; Taya, Y.; Ito, H.; Numabe, Y. Effects of theaflavins on tissue inflammation and bone resorption on experimental periodontitis in rats. J. Periodontal Res. 2018, 53, 1009–1019. [Google Scholar] [CrossRef] [PubMed]
  6. Isola, G.; Polizzi, A.; Santonocito, S.; Alibrandi, A.; Ferlito, S. Expression of Salivary And Serum Malondialdehyde And Lipid Profile Of Patients With Periodontitis And Coronary Heart Disease. Int. J. Mol. Sci. 2019, 20, 6061. [Google Scholar] [CrossRef] [PubMed]
  7. Isola, G.; Matarese, G.; Ramaglia, L.; Pedullà, E.; Rapisarda, E.; Iorio-Siciliano, V. Association between periodontitis and glycosylated haemoglobin before diabetes onset: A cross-sectional study. Clin. Oral Investig. 2019. [Google Scholar] [CrossRef] [PubMed]
  8. Patini, R.; Staderini, E.; Gallenzi, P. Multidisciplinary surgical management of Cowden syndrome: Report of a case. J. Clin. Exp. Dent. 2016, 8, e472. [Google Scholar] [CrossRef]
  9. Facciolo, M.T.; Riva, F.; Gallenzi, P.; Patini, R.; Gaglioti, D. A rare case of oral multisystem Langerhans cell histiocytosis. J. Clin. Exp. Dent. 2017, 9, e820. [Google Scholar] [CrossRef]
  10. Nilsson, H.; Berglund, J.S.; Renvert, S. Periodontitis, tooth loss and cognitive functions among older adults. Clin. Oral Investig. 2018, 22, 2103–2109. [Google Scholar] [CrossRef]
  11. Isola, G.; Anastasi, G.; Matarese, G.; Williams, R.C.; Cutroneo, G.; Bracco, P.; Piancino, M.G. Functional and molecular outcomes of the human masticatory muscles. Oral Dis. 2018, 8, 1424–1441. [Google Scholar] [CrossRef]
  12. Isola, G.; Polizzi, A.; Alibrandi, A.; Indelicato, F.; Ferlito, S. Analysis of Endothelin-1 concentrations in individuals with periodontitis. Sci. Rep. 2020, 10, 1652. [Google Scholar] [CrossRef]
  13. Staderini, E.; Patini, R.; de Luca, M.; Gallenzi, P. Three-dimensional stereophotogrammetric analysis of nasolabial soft tissue effects of rapid maxillary expansion: A systematic review of clinical trials. Acta Otorhinolaryngol. Ital. 2018, 38, 399–408. [Google Scholar] [PubMed]
  14. Isola, G.; Perillo, L.; Migliorati, M.; Matarese, M.; Dalessandri, D.; Grassia, V.; Alibrandi, A.; Matarese, G. The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis. Eur. J. Orthod. 2019, 41, 117–124. [Google Scholar] [CrossRef] [PubMed]
  15. Isola, G.; Alibrandi, A.; Rapisarda, E.; Matarese, G.; Williams, R.C.; Leonardi, R. Association of Vitamin d in patients with periodontitis: A cross-sectional study. J. Periodontal Res. 2020. In Press. [Google Scholar]
  16. Nadelman, P.; Magno, M.B.; Masterson, D.; da Cruz, A.G.; Maia, L.C. Are dairy products containing probiotics beneficial for oral health? A systematic review and meta-analysis. Clin. Oral Investig. 2018, 22, 2763–2785. [Google Scholar] [CrossRef] [PubMed]
  17. Isola, G.; Lo Giudice, A.; Polizzi, A.; Alibrandi, A.; Patini, R.; Ferlito, S. Periodontitis and Tooth Loss Have Negative Systemic Impact on Circulating Progenitor Cell Levels: A Clinical Study. Genes 2019, 10, 1022. [Google Scholar] [CrossRef]
  18. Pippi, R.; Santoro, M.; Patini, R. The central odontogenic fibroma: How difficult can be making a preliminary diagnosis. J. Clin. Exp. Dent. 2016, 8, e223–e225. [Google Scholar] [CrossRef]
  19. Grassia, V.; D’Apuzzo, F.; Ferrulli, V.E.; Matarese, G.; Femiano, F.; Perillo, L. Dento-skeletal effects of mixed palatal expansion evaluated by postero-anterior cephalometric analysis. Eur. J. Paediatr Dent. 2014, 15, 59–62. [Google Scholar]
  20. Grassia, V.; D’Apuzzo, F.; Di Stasio, D.; Jamilian, A.; Lucchese, A.; Perillo, L. Upper and lower arch changes after Mixed Palatal Expansion protocol. Eur. J. Paediatr Dent. 2014, 15, 375–380. [Google Scholar]
  21. Moura, M.F.; Navarro, T.P.; Silva, T.A.; Cota, L.O.M. Soares Dutra Oliveira AM, Costa FO. Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1β, Tumor Necrosis Factor-α, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide. J. Periodontol. 2017, 88, 778–787. [Google Scholar]
  22. Coviello, V.; Zareh Dehkhargani, S.; Patini, R.; Cicconetti, A. Surgical ciliated cyst 12 years after Le Fort I maxillary advancement osteotomy: A case report and review of the literature. Oral Surg. 2017, 10, 165–170. [Google Scholar] [CrossRef]
  23. Isola, G.; Matarese, M.; Ramaglia, L.; Iorio-Siciliano, V.; Cordasco, G.; Matarese, G. Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: A randomized, triple-blind, controlled clinical trial. Clin. Oral Investig. 2019, 23, 2443–2453. [Google Scholar] [CrossRef] [PubMed]
  24. Grassia, V.; Lombardi, A.; Kawasaki, H.; Ferri, C.; Perillo, L.; Mosca, L.; Delle Cave, D.; Nucci, L.; Porcelli, M.; Caraglia, M. Salivary microRNAs as new molecular markers in cleft lip and palate: A new frontier in molecular medicine. Oncotarget 2018, 9, 18929–18930. [Google Scholar] [CrossRef] [PubMed]
  25. Kırzıoğlu, F.Y.; Özmen, Ö.; Doğan, B.; Bulut, M.T.; Fentoğlu, Ö.; Özdem, M. Effects of rosuvastatin on inducible nitric oxide synthase in rats with hyperlipidaemia and periodontitis. J. Periodontal Res. 2018, 53, 258–266. [Google Scholar] [CrossRef]
  26. Nastri, L.; de Rosa, A.; de Gregorio, V.; Grassia, V.; Donnarumma, G. A New Controlled-Release Material Containing Metronidazole and Doxycycline for the Treatment of Periodontal and Peri-Implant Diseases: Formulation and in Vitro Testing. Int. J. Dent. 2019, 2019, 9374607. [Google Scholar] [CrossRef]
  27. Isola, G.; Polizzi, A.; Muraglie, S.; Leonardi, R.M.; Lo Giudice, A. Assessment of vitamin C and Antioxidants Profiles In Saliva and Serum in Patients With Periodontitis and Ischemic Heart Disease. Nutrients 2019, 11, 2956. [Google Scholar] [CrossRef]
  28. Isola, G.; Alibrandi, A.; Currò, M.; Matarese, M.; Ricca, S.; Matarese, G.; Ientile, R.; Kocher, T. Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J. Periodontol. 2020. [Google Scholar] [CrossRef]
  29. Isola, G.; Matarese, M.; Ramaglia, L.; Cicciù, M.; Matarese, G. Evaluation of the efficacy of celecoxib and ibuprofen on postoperative pain, swelling, and mouth opening after surgical removal of impacted third molars: A randomized, controlled clinical trial. Int. J. Oral Maxillofac. Surg. 2019, 48, 1348–1354. [Google Scholar] [CrossRef]
  30. Loreto, C.; Almeida, L.E.; Trevilatto, P.; Leonardi, R. Apoptosis in displaced temporomandibular joint disc with and without reduction: An immunohistochemical study. J. Oral Pathol. Med. 2011, 40, 103–110. [Google Scholar] [CrossRef]
  31. Leonardi, R.; Lo Giudice, A.; Rugeri, M.; Muraglie, S.; Cordasco, G.; Barbato, E. Three-dimensional evaluation on digital casts of maxillary palatal size and morphology in patients with functional posterior crossbite. Eur. J. Orthod. 2018, 40, 556–562. [Google Scholar] [CrossRef]
  32. Lo Giudice, A.; Nucera, R.; Perillo, L.; Paiusco, A.; Caccianiga, G. Is low-level laser therapy an effective method to alleviate pain induced by active orthodontic alignment archwire? A randomized clinical trial. J. Evid. Based Dent. Pract. 2019, 19, 71–78. [Google Scholar] [CrossRef] [PubMed]
  33. Lo Giudice, A.; Barbato, E.; Cosentino, L.; Ferraro, C.M.; Leonardi, R. Alveolar bone changes after rapid maxillary expansion with tooth-born appliances: A systematic review. Eur. J. Orthod. 2018, 40, 296–303. [Google Scholar] [CrossRef] [PubMed]
  34. Lo Giudice, A.; Caccianiga, G.; Crimi, S.; Cavallini, C.; Leonardi, R. Frequency and type of ponticulus posticus in a longitudinal sample of nonorthodontically treated patients: Relationship with gender, age, skeletal maturity, and skeletal malocclusion. Oral. Surg. Oral. Med. Oral Pathol. Oral. Radiol. 2018, 126, 291–297. [Google Scholar] [CrossRef] [PubMed]
  35. Scalzone, A.; Flores-Mir, C.; Carozza, D.; D’Apuzzo, F.; Grassia, V.; Perillo, L. Secondary alveolar bone grafting using autologous versus alloplastic material in the treatment of cleft lip and palate patients: Systematic review and meta-analysis. Prog. Orthod. 2019, 20, 6. [Google Scholar] [CrossRef]
  36. Piancino, M.G.; Isola, G.; Cannavale, R.; Cutroneo, G.; Vermiglio, G.; Bracco, P.; Anastasi, G.P. From periodontal mechanoreceptors to chewing motor control: A systematic review. Arch. Oral Biol. 2017, 78, 109–121. [Google Scholar] [CrossRef]
  37. Zeidán-Chuliá, F.; Yilmaz, D.; Häkkinen, L.; Könönen, E.; Neves de Oliveira, B.H.; Güncü, G.; Uitto, V.J.; Caglayan, F.; Gürsoy, U.K. Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus. J. Periodontal Res. 2018, 53, 916–923. [Google Scholar] [CrossRef]
  38. Cutroneo, G.; Piancino, M.G.; Ramieri, G.; Bracco, P.; Vita, G.; Isola, G.; Vermiglio, G.; Favaloro, A.; Anastasi, G.; Trimarchi, F. Expression of muscle-specific integrins in masseter muscle fibers during malocclusion disease. Int. J. Mol. Med. 2012, 30, 235–242. [Google Scholar] [CrossRef]
  39. Scarel-Caminaga, R.M.; Cera, F.F.; Pigossi, S.C.; Finoti, L.S.; Kim, Y.J.; Viana, A.C.; Secolin, R.; Montenegro, M.F.; Tanus-Santos, J.E.; Orrico, S.R.P.; et al. Inducible Nitric Oxide Synthase Polymorphisms and Nitric Oxide Levels in Individuals with Chronic Periodontitis. Int. J. Mol. Sci. 2017, 18, 1128. [Google Scholar] [CrossRef]
Back to TopTop